Starting a telehealth business is an exciting venture, but it comes with its own set of challenges, none more daunting than ...

Telemedicine is transforming post-surgical recovery, offering safer and more convenient care that improves access, and ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...

If there has been one singular public policy change in recent years that formally acknowledges family caregivers as part of the caregiving ecosystem, it is on the Medicare side.

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...

Novo Nordisk announced it is making the popular weight loss medication available to three telehealth companies and revealed plans to make it more affordable for those paying out-of-pocket.

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply ...

Telemedicine has grown exponentially. While it has its issues, when appropriate, it has allowed patients to be treated for an ...

Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of more than 130,000 exhaust-spewing ...